What's on?

Tuesday, 2 May: World Asthma Day

25 Apr 2017 | By Inserm (Newsroom) | International day

Asthme chez l'enfant

Asthme chez l’enfant : test de la fonction pulmonaire (spirométrie)

©Inserm/ Latron, Patrice

On the initiative of WHO, World Vaccination Week is the opportunity to raise public awareness of the vital importance of vaccination throughout life.

The number of children in the world who are not vaccinated or are inadequately vaccinated is 19.4 million, according to WHO.

In France, the latest data from the Institute of Health Monitoring (InVS) indicate that in children, there is vaccination coverage of 91% against diphtheria, tetanus, polio and whooping cough. With regard to vaccination coverage of Measles, Mumps, Rubella (MMR), it is only 72% in children of 24 months.

To understand the individual and collective challenges of vaccination, in partnership with Muscadier publications, Inserm has published an educational manual explaining the function of vaccines, their role and their benefits but also their limits:

Vaccination: Agression or Protection? “, in the Choc Santé collection, edited by Annick Guimenazes, an Inserm researcher at the Marseille-Luminy Centre of Immunology (CIML) and Marion Mathieu, Doctor of Biology and engineer at ESPCI-ParisTech.

The recent occurrence of epidemics and pandemics – the Ebola epidemic in West Africa and that of Zika in the Americas, have highlighted the urgency of developing vaccines, by creating innovative partnerships between the different participants in global vaccine research.

For Yves Lévy, Chairman and CEO of Inserm: “The Ebola epidemic proved that we can develop vaccines quickly in extremely difficult conditions. It also proved that one of the keys to success is the willingness of all those involved to work hand in hand.”

Inserm, the National Institutes of Health (NIH) in the United States and the London School of Hygiene & Tropical Medicine, LSHTM, in collaboration with the health authorities of Guinea and Liberia, have launched a new clinical trial on the Ebola vaccine candidates, under the aegis of the PREVAC (Partnership for Research on Ebola VACcination) international consortium. 

Read the report “Ebola: a new clinical trial launched in West Africa to assess three vaccination strategies” published on 6 April in the Inserm Press Room.

See also the vaccination file on the Inserm site.

These contents could be interesting :

Researcher Contact

Isabella Annesi-Maesano
Directrice de recherche Inserm
Unité Inserm 1136 « Institut Pierre Louis d’épidémiologie et de santé publique»
01 44 73 84 49

Jocelyne Just
Directrice de recherche Inserm
Unité Inserm 1136 « Institut Pierre Louis d’épidémiologie et de santé publique »
01 44 73 63 81

Antoine Magnan
Responsable de l’équipe « Immunopathologie des maladies respiratoires»
Unité Inserm 1087, L’Institut du Thorax
02 28 08 01 26

Patrick Berger
Directeur de l’équipe Inserm « Remodelage bronchique »
Unité Inserm 1045, Centre de recherche cardio-thoracique de Bordeaux
05 57 57 56 75

Jean-Charles Guéry
Directrice de recherche Inserm
Unité Inserm 1043,  Centre de Physiopathologie Toulouse-Purpan
05 62 74 83 78